Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 0 | 0 | 0.34 | 4.29 |
| Operating Revenue | - | 0 | 0 | 0.34 | 4.29 |
| Cost Of Revenue | - | - | 0 | 3.30 | 14.86 |
| Gross Profit | - | - | 0 | -2.96 | -10.57 |
| Operating Expense | - | 33.55 | 22.43 | 34.55 | 31.45 |
| Research And Development | - | 0.96 | 7.57 | 14.33 | 8.47 |
| Selling General And Administration | - | 31.70 | 12.85 | 16.11 | 21.15 |
| Total Expenses | - | 33.55 | 22.43 | 37.86 | 46.31 |
| Operating Income | - | -33.55 | -22.43 | -37.52 | -42.02 |
| Total Operating Income As Reported | -37.72 | - | - | - | - |
| EBITDA | - | -33.43 | -21.86 | -50.56 | -41.58 |
| Normalized EBITDA | - | -33.36 | -22.15 | -39.91 | -40.20 |
| EBIT | - | -33.54 | -22.06 | -52.34 | -46.74 |
| Interest Expense | - | 0 | 0.13 | 0.16 | 0.02 |
| Net Interest Income | - | 0 | -0.13 | -4.35 | -3.80 |
| Other Non Operating Income Expenses | - | 0.07 | 0.08 | 0.02 | 0.44 |
| Other Income Expense | - | 0.01 | 0.37 | -10.63 | -0.94 |
| Interest Expense Non Operating | - | 0 | 0.13 | 0.16 | 0.02 |
| Net Non Operating Interest Income Expense | - | 0 | -0.13 | -4.35 | -3.80 |
| Pretax Income | - | -33.54 | -22.19 | -52.50 | -46.76 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 0 | 0 | 0 | 0 |
| Net Income Continuous Operations | - | -33.54 | -22.19 | -52.50 | -46.76 |
| Net Income From Continuing And Discontinued Operation | - | -33.54 | -22.19 | -52.50 | -46.76 |
| Net Income From Continuing Operation Net Minority Interest | - | -33.54 | -22.19 | -52.50 | -46.76 |
| Net Income | - | -33.54 | -22.19 | -52.50 | -46.76 |
| Net Income Common Stockholders | - | -33.54 | -22.19 | -52.50 | -46.76 |
| Net Income Including Noncontrolling Interests | - | -33.54 | -22.19 | -52.50 | -46.76 |
| Normalized Income | - | -33.48 | -22.48 | -41.85 | -45.38 |
| Diluted NI Availto Com Stockholders | - | -33.54 | -22.19 | -52.50 | -46.76 |
| Basic Average Shares | - | 41.72 | 43.75 | 51.24 | 80.32 |
| Diluted Average Shares | - | 41.72 | 43.75 | 51.24 | 80.32 |
| Reconciled Depreciation | - | 0.11 | 0.20 | 1.78 | 5.16 |
| Reconciled Cost Of Revenue | - | - | 0 | 3.30 | 14.86 |
| Total Unusual Items | - | -0.06 | 0.29 | -10.66 | -1.39 |
| Total Unusual Items Excluding Goodwill | - | -0.06 | 0.29 | -10.66 | -1.39 |
| Special Income Charges | - | -0.03 | 0.30 | -10.25 | -2.09 |
| Other Special Charges | -18.94 | - | - | - | 0.68 |
| Impairment Of Capital Assets | - | 0.19 | 0 | 10.25 | 0 |
| Restructuring And Mergern Acquisition | - | - | - | 0 | 1.42 |
| Gain On Sale Of Security | - | -0.03 | -0.01 | -0.40 | 0.71 |
| General And Administrative Expense | - | 31.70 | 12.85 | 16.11 | 21.15 |
| Other Gand A | - | 31.70 | 12.85 | 16.11 | 21.15 |
| Gain On Sale Of Ppe | 0 | 0.15 | 0.30 | 0 | - |
| Total Other Finance Cost | 0.42 | - | - | 4.19 | 3.78 |
| Other Operating Expenses | - | 0.89 | 2.01 | 4.12 | 1.83 |
| Otherunder Preferred Stock Dividend | 0.10 | - | - | - | - |
